Valeant Plans To Restate Results In Wake Of Pharmacy Crisis
Valeant Pharmaceuticals International Inc. on Monday said it plans to restate some financial results for past years, after an internal review into its relationship with a controversial specialty pharmacy revealed that...To view the full article, register now.
Already a subscriber? Click here to view full article